Brief: Biorestorative Therapies Enters Into Agreement With Regenexx
Dec 5 (Reuters) - BioRestorative Therapies Inc BRTX.O :
* BIORESTORATIVE THERAPIES ENTERS AGREEMENT WITH REGENEXX,
GRANTING BRTX EXCLUSIVE LICENSE RIGHTS FOR INTELLECTUAL PROPERTY
RELATED TO THE DEVELOPMENT AND COMMERCIALIZATION OF ITS
BRTX-100® DISC PROGRAM TO TREAT CHRONIC LUMBAR DISC DISEASE
Source text for Eikon: ID:nGNX5z16fH
Further company coverage: BRTX.O
Recent news on Biorestorative Therapies
See all newsBioRestorative Therapies Inc expected to post a loss of $2.50 a share - Earnings Preview
BioRestorative Therapies Inc expected to post a loss of $2.50 a share - Earnings Preview
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM